In Section A, contributors will obtain distinct doses and schedules of oral ABBV-744 pill to identify Safe and sound dosing program. Further members will probably be enrolled with the discovered monotherapy dosign regimen. In Phase B, contributors will receive oral ruxolitinib and ABBV-744 is going to be given as "include-on" https://elliotxeqcn.ja-blog.com/31996012/a-simple-key-for-abbv-744-brd4-inhibition-in-cancer-cell-lines-unveiled